147 related articles for article (PubMed ID: 3526477)
1. Preoperative (neoadjuvant) chemotherapy for breast cancer: outline of the British Columbia Trial.
Ragaz J
Recent Results Cancer Res; 1986; 103():85-94. PubMed ID: 3526477
[No Abstract] [Full Text] [Related]
2. Neoadjuvant-preoperative-chemotherapy for breast cancer--preliminary report of the Vancouver trial.
Ragaz J; Baird R; Rebbeck P; Coldman A; Goldie J
Prog Clin Biol Res; 1985; 201():77-87. PubMed ID: 3912768
[No Abstract] [Full Text] [Related]
3. Adjuvant systemic therapy in primary breast cancer.
Mouridsen HT; Palshof T
Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
[No Abstract] [Full Text] [Related]
4. Adjuvant treatment in node-negative, postmenopausal breast cancer.
Hutchins LF; Arick CL
Cancer Invest; 2001; 19(7):706-22. PubMed ID: 11577812
[No Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.
Albain KS
J Natl Cancer Inst; 2004 Dec; 96(24):1801-4. PubMed ID: 15601631
[No Abstract] [Full Text] [Related]
6. Preoperative adjuvant chemotherapy (neoadjuvant) for carcinoma of the breast: rationale and safety report.
Ragaz J; Baird R; Rebbeck P; Goldie A; Coldman A; Spinelli J
Recent Results Cancer Res; 1985; 98():99-105. PubMed ID: 3839932
[No Abstract] [Full Text] [Related]
7. Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.
Wallgren A; Baral E; Beling U; Carstensen J; Friberg S; Glas U; Kaigas M; Skoog L
Recent Results Cancer Res; 1984; 96():197-203. PubMed ID: 6396775
[No Abstract] [Full Text] [Related]
8. Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
Gelber RD
Recent Results Cancer Res; 1984; 96():102-9. PubMed ID: 6396763
[No Abstract] [Full Text] [Related]
9. Adjuvant systemic therapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group's trials of cyclophosphamide or CMF in premenopausal and tamoxifen in postmenopausal patients.
Mouridsen HT; Rose C; Brincker H; Thorpe SM; Rank F; Fischerman K; Andersen KW
Recent Results Cancer Res; 1984; 96():117-28. PubMed ID: 6396765
[No Abstract] [Full Text] [Related]
10. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
[TBL] [Abstract][Full Text] [Related]
11. Emerging modalities for adjuvant therapy of breast cancer: neoadjuvant chemotherapy.
Ragaz J
NCI Monogr; 1986; (1):145-52. PubMed ID: 3534588
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy for breast cancer: a brief overview of the NSABP experience and some thoughts on neoadjuvant chemotherapy.
Fisher B
Recent Results Cancer Res; 1986; 103():54-68. PubMed ID: 3526476
[No Abstract] [Full Text] [Related]
13. A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
Howell A; Rubens RD; Bush H; George WD; Howat JM; Crowther D; Sellwood RA; Hayward JL; Knight RK; Bulbrook RD
Recent Results Cancer Res; 1984; 96():74-89. PubMed ID: 6396780
[No Abstract] [Full Text] [Related]
14. Perioperative and conventionally timed chemotherapy in operable breast cancer: the Ludwig Breast Cancer Study V.
Goldhirsch A; Gelber R
Recent Results Cancer Res; 1986; 103():103-12. PubMed ID: 3526472
[No Abstract] [Full Text] [Related]
15. Perioperative adjuvant chemotherapy of breast cancer: the Scandinavian experience.
Nissen-Meyer R; Host H; Kjellgren K; Mansson B; Norin T
Recent Results Cancer Res; 1986; 103():95-102. PubMed ID: 3526478
[No Abstract] [Full Text] [Related]
16. Evolving concepts in the systemic adjuvant treatment of breast cancer.
Bonadonna G
Cancer Res; 1992 Apr; 52(8):2127-37. PubMed ID: 1559216
[No Abstract] [Full Text] [Related]
17. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
Henderson IC
J Clin Oncol; 1985 Feb; 3(2):140-3. PubMed ID: 3881560
[No Abstract] [Full Text] [Related]
18. Currently active protocols in the EORTC Breast Cancer Cooperative Group.
Mouridsen HT; Palshof T; Mattheiem W; Sylvester RJ; Rotmensz N; Paridaens RJ
Recent Results Cancer Res; 1984; 91():263-7. PubMed ID: 6374800
[No Abstract] [Full Text] [Related]
19. Adjuvant chemotherapy for node-negative breast cancer patients.
Bonadonna G; Zambetti M; Valagussa P
Recent Results Cancer Res; 1989; 115():175-9. PubMed ID: 2516350
[No Abstract] [Full Text] [Related]
20. Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
Howell A; Bush H; George WD; Howat JM; Crowther D; Sellwood RA; Rubens RD; Hayward JL; Bulbrook RD; Fentiman IS
Lancet; 1984 Aug; 2(8398):307-11. PubMed ID: 6146861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
